Authors:
DONNELLY SC
HASLETT C
REID PT
GRANT IS
WALLACE WAH
METZ CN
BRUCE LJ
BUCALA R
Citation: Sc. Donnelly et al., REGULATORY ROLE FOR MACROPHAGE-MIGRATION INHIBITORY FACTOR IN ACUTE RESPIRATORY-DISTRESS SYNDROME, Nature medicine, 3(3), 1997, pp. 320-323
Authors:
STITT AW
HE CJ
FRIEDMAN S
SCHER L
ROSSI P
ONG L
FOUNDS H
LI YM
BUCALA R
VLASSARA H
Citation: Aw. Stitt et al., ELEVATED AGE-MODIFIED APO-B IN SERA OF EUGLYCEMIC, NORMOLIPIDEMIC PATIENTS WITH ATHEROSCLEROSIS - RELATIONSHIP TO TISSUE AGES, Molecular medicine, 3(9), 1997, pp. 617-627
Authors:
LAN HY
YANG NS
METZ C
MU W
SONG Q
NIKOLICPATERSON DJ
BACHER M
BUCALA R
ATKINS RC
Citation: Hy. Lan et al., TNF-ALPHA UP-REGULATES RENAL MIF EXPRESSION IN RAT CRESCENTIC GLOMERULONEPHRITIS, Molecular medicine, 3(2), 1997, pp. 136-144
Authors:
PUSHKARSKY T
ROURKE L
SPIEGEL LA
SELDIN MF
BUCALA R
Citation: T. Pushkarsky et al., MOLECULAR CHARACTERIZATION OF A MOUSE GENOMIC ELEMENT MOBILIZED BY ADVANCED GLYCATION ENDPRODUCT MODIFIED-DNA (AGE-DNA), Molecular medicine, 3(11), 1997, pp. 740-749
Citation: R. Bucala, LIPOPROTEIN MODIFICATION BY ADVANCED GLYCOSYLATION ENDPRODUCTS (AGES)- ROLE IN ATHEROSCLEROSIS, Trends in cardiovascular medicine, 7(2), 1997, pp. 39-47
Citation: T. Calandra et R. Bucala, MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) - A GLUCOCORTICOID COUNTER-REGULATOR WITHIN THE IMMUNE-SYSTEM, Critical reviews in immunology, 17(1), 1997, pp. 77-88
Citation: R. Bucala, LIPID AND LIPOPROTEIN MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS - ROLE IN ATHEROSCLEROSIS, Experimental physiology, 82(2), 1997, pp. 327-337
Citation: Y. Alabed et R. Bucala, EFFICIENT SCAVENGING OF FATTY-ACID OXIDATION-PRODUCTS BY AMINOGUANIDINE, Chemical research in toxicology, 10(8), 1997, pp. 875-879
Authors:
VANPATTEN S
ALABED Y
LI H
LAWSON JA
FITZGERALD GA
BUCALA R
Citation: S. Vanpatten et al., HIGH-RESOLUTION SUBFRACTION ANALYSIS OF HEMOGLOBIN BY LC-MS - LOCALIZATION OF A CARBOXYMETHYL ADDUCT TO THE HEMOGLOBIN BETA-CHAIN (HB-CM) AND INCREASED LEVELS IN DIABETES-MELLITUS, The FASEB journal, 11(9), 1997, pp. 3316-3316
Authors:
ALABED Y
VANPATTEN S
LI H
LAWSON JA
FITZGERALD GA
BUCALA R
Citation: Y. Alabed et al., STRUCTURAL CHARACTERIZATION OF A NEW GLYCATED HEMOGLOBIN - INTERMEDIATE IN THE PATHWAY TO AGE CROSS-LINK FORMATION, The FASEB journal, 11(9), 1997, pp. 3317-3317
Authors:
BERNHAGEN J
KLEEMANN R
KAPURNIOTU A
BUCALA R
BRUNNER H
Citation: J. Bernhagen et al., THE CYTOKINE MIF HAS ENZYMATIC REDOX ACTIVITY - PROOF OF ROLE FOR CYSTEINES, The FASEB journal, 11(9), 1997, pp. 3421-3421
Authors:
GRAB DJ
DIDIER P
CHESNEY J
GIVENS C
KENNEDY R
LANNERS N
MARTIN L
BUCALA R
Citation: Dj. Grab et al., BORRELIA-BURGDORFERI BIND TO PERIPHERAL-BLOOD FIBROCYTES - LEUKOCYTE-LIKE CELLS WITH POTENTIAL FOR CONNECTIVE-TISSUE TARGETING, The FASEB journal, 11(3), 1997, pp. 672-672
Citation: J. Chesney et R. Bucala, PERIPHERAL-BLOOD FIBROCYTES - NOVEL FIBROBLAST-LIKE CELLS THAT PRESENT ANTIGEN AND MEDIATE TISSUE-REPAIR, Biochemical Society transactions, 25(2), 1997, pp. 520-524
Authors:
MACKINNON JR
SWA K
DONNELLY S
NICHOLL I
BUCALA R
MITSUHASHI T
OBRIEN C
Citation: Jr. Mackinnon et al., ADVANCED GLYCOSYLATED END-PRODUCTS IN DIABETIC-RETINOPATHY, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3555-3555
Authors:
FISHBANE S
BUCALA R
PEREIRA BJG
FOUNDS H
VLASSARA H
Citation: S. Fishbane et al., REDUCTION OF PLASMA APOLIPOPROTEIN-B BY EFFECTIVE REMOVAL OF CIRCULATING GLYCATION DERIVATIVES IN UREMIA, Kidney international, 52(6), 1997, pp. 1645-1650
Authors:
LAN HY
MU W
YANG N
MEINHARDT A
NIKOLICPATERSON D
BACHER M
ATKINS RC
BUCALA R
Citation: Hy. Lan et al., MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) - A PREVIOUSLY UNRECOGNIZED KIDNEY-DERIVED CYTOKINE WHICH PARTICIPATES IN LOCAL MACROPHAGE ACCUMULATION AND PROLIFERATION IN THE PROGRESSION OF RAT ANTI-GBM GLOMERULONEPHRITIS, Kidney international, 51(4), 1997, pp. 1313-1314
Authors:
WAEBER G
CALANDRA T
RODUIT R
HAEFLIGER JA
BONNY C
THOMPSON N
THORENS B
TEMLER E
MEINHARDT A
BACHER M
METZ CN
NICOD P
BUCALA R
Citation: G. Waeber et al., INSULIN-SECRETION IS REGULATED BY THE GLUCOSE-DEPENDENT PRODUCTION OFISLET BETA-CELL MACROPHAGE-MIGRATION INHIBITORY FACTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 94(9), 1997, pp. 4782-4787
Authors:
CERAMI C
FOUNDS H
NICHOLL I
MITSUHASHI T
GIORDANO D
VANPATTEN S
LEE A
ALABED Y
VLASSARA H
BUCALA R
CERAMI A
Citation: C. Cerami et al., TOBACCO-SMOKE IS A SOURCE OF TOXIC REACTIVE GLYCATION PRODUCTS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(25), 1997, pp. 13915-13920
Citation: J. Chesney et al., THE PERIPHERAL-BLOOD FIBROCYTE IS A POTENT ANTIGEN-PRESENTING CELL CAPABLE OF PRIMING NAIVE T-CELLS IN-SITU, Proceedings of the National Academy of Sciences of the United Statesof America, 94(12), 1997, pp. 6307-6312
Authors:
KOSCHINSKY T
HE CJ
MITSUHASHI T
BUCALA R
LIU C
BUENTING C
HEITMANN K
VLASSARA H
Citation: T. Koschinsky et al., ORALLY ABSORBED REACTIVE GLYCATION PRODUCTS (GLYCOTOXINS) - AN ENVIRONMENTAL RISK FACTOR IN DIABETIC NEPHROPATHY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(12), 1997, pp. 6474-6479
Authors:
BERG TJ
BANGSTAD HJ
TORJESEN PA
OSTERBY R
BUCALA R
HANSSEN KF
Citation: Tj. Berg et al., ADVANCED GLYCATION END-PRODUCTS IN SERUM PREDICT CHANGES IN THE KIDNEY MORPHOLOGY OF PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS, Metabolism, clinical and experimental, 46(6), 1997, pp. 661-665
Citation: A. Mikulowska et al., MACROPHAGE-MIGRATION INHIBITORY FACTOR IS INVOLVED IN THE PATHOGENESIS OF COLLAGEN TYPE II-INDUCED ARTHRITIS IN MICE, The Journal of immunology, 158(11), 1997, pp. 5514-5517
Authors:
LAN HY
YANG NS
MU W
NIKOLICPATERSON DJ
METZ C
MEINHARDT A
BUCALA R
ATKINS RC
Citation: Hy. Lan et al., THE PATHOGENIC ROLE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR IN IMMUNOLOGICALLY INDUCED KIDNEY-DISEASE IN THE RAT, The Journal of experimental medicine, 185(8), 1997, pp. 1455-1465
Citation: Y. Alabed et R. Bucala, A NOVEL AGE CROSS-LINK THAT EXHIBITS IMMUNOLOGICAL CROSS-REACTIVITY WITH IN VIVO-FORMED AGES, Diabetes, 46, 1997, pp. 271-271
Citation: Y. Alabed et R. Bucala, EFFICIENT SCAVENGING OF LIPID OXIDATION-PRODUCTS BY AMINOGUANIDINE - POSSIBLE ROLE IN THE ANTI-ATHEROGENIC EFFECTS OF AMINOGUANIDINE, Diabetes, 46, 1997, pp. 441-441